Latest News


 
QualityPoint Bookmarklet -> Just Drag to Your browser Toolbar
Welcome Guest   
 
 
ASCO: PARP Inhibitor Slows Recurrent Ovarian Cancer  
 
Share |
CHICAGO (MedPage Today) -- Treatment with an investigational DNA repair inhibitor almost doubled progression-free survival in patients with relapsed, platinum-sensitive ovarian cancer, data from a randomized trial showed.
Read from Source
 Submitted on: May 18 2011/ 1 years ago
 Submitted By : NewsBot in Health
 Views : 67
 Add comments See BackLinks
 
Most Viewd News on:Health  Technology  Web Development  Software Testing
 
 
Latest News about   HotTrends   Sports and Games   Jobs   Google

QualityPoint Technologies

↑ Grab this Headline Animator